VistaGen Therapeutics (VTGN) EBITDA (2010 - 2026)
VistaGen Therapeutics (VTGN) EBITDA from Jun 30, 2010 to Mar 31, 2026. The TTM VistaGen Therapeutics (VTGN) EBITDA is -$72M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
VistaGen Therapeutics (VTGN) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +28.86% |
| 3 Years TTM | +6.74% |
| 5 Years TTM | +32.19% |
| 10 Years TTM | +14.99% |
| All Time TTM | +16.40% |
Annual EBITDA change of VistaGen Therapeutics (VTGN)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | -$72M | +28.86% |
| 2025 | -$56M | +69.72% |
| 2024 | -$33M | -44.39% |
| 2023 | -$59M | N/A |
| 2022 | $0 | -100.00% |
| 2021 | -$11M | N/A |
| 2020 | $0 | -100.00% |
| 2019 | -$5.96M | -17.45% |
| 2018 | -$7.22M | +140.67% |
| 2017 | -$3M | +13.64% |
| 2016 | -$2.64M | +23.36% |
| 2015 | -$2.14M | +613.33% |
| 2014 | -$300K | +30.43% |
| 2013 | -$230K | -95.87% |
| 2012 | -$5.57M | +12.53% |
| 2011 | -$4.95M | +20.15% |
| 2010 | -$4.12M | -12.34% |
| 2009 | -$4.70M | -13.76% |
| 2008 | -$5.45M | +172.50% |
| 2007 | -$2M | +12.99% |
| 2006 | -$1.77M | +63.89% |
| 2005 | -$1.08M | -87.67% |
| 2004 | -$8.76M | +1652.00% |
| 2003 | -$500K | -76.30% |
| 2002 | -$2.11M | +16.57% |
| 2001 | -$1.81M | +158.57% |
| 2000 | -$700K | N/A |
Comparison VistaGen Therapeutics (VTGN) five years EBITDA CAGR with competitors
VistaGen Therapeutics (VTGN) five years EBITDA CAGR is 32.20%.